MOTS-c
MOTS-c is a 16 amino acid mitochondrial-derived peptide encoded in the 12S rRNA gene. First mitochondrial peptide to enter clinical trials. Emerging evidence for metabolic health, exercise performance, and longevity. Levels decline with age.
Research-reported dosing only. Not medical advice. Consult a healthcare provider.
At A Glance
Activates AMPK through the folate-AICAR pathway, improves glucose metabolism, and can translocate to the nucleus to regulate stress-response genes.
Activates AMP-activated protein kinase through the folate-AICAR pathway, serving as master metabolic regulator.
Induces metabolic adaptations similar to physical exercise, improving glucose uptake and fat oxidation in skeletal muscle.
Restores age-related muscle insulin resistance (proposed), and treatment may reverse metabolic decline.
Can move from mitochondria to nucleus during metabolic stress, directly regulating nuclear gene expression for stress response.
Circulating levels decrease with age in both humans and mice, associated with metabolic decline.
Specific polymorphism (m.1382A>C) associated with exceptional longevity in Japanese centenarians, genetic evidence for longevity role
Read Full MOTS-c Dosage Guide
Research-backed dosing protocols, timing, and administration details
Browse more in this category
Longevity & Cellular Health
Clinical Trials for Peptide Drugs Are Surging: Why the Pipeline Is Exploding in 2026
Peptide clinical trials have surged dramatically, with over 150 peptides now in active trials and 400+ in preclinical development. Here's why peptides are becoming the dominant drug class and what it means for the future of medicine.
MOTS-c Peptide: Benefits, Mechanism, and What the Research Shows
MOTS-c is the first peptide discovered to be encoded by mitochondrial DNA. New research links it to exercise mimicry, insulin sensitivity, and cellular aging reversal.
RFK Jr. Says 14 Peptides Are Coming Back: FDA Category 2 Ban Reversal Explained
HHS Secretary RFK Jr. told Joe Rogan that ~14 peptides banned by the FDA in 2023 will return to Category 1, restoring legal compounding access.
GHK-Cu for Skin, Hair, and Anti-Aging: What the Research Shows
GHK-Cu is a naturally occurring copper peptide that declines with age. Research shows it stimulates collagen, promotes wound healing, and may reverse aspects of gene expression associated with aging. Here's what the science says.